Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen (AMGN) Stock Outperforms Industry YTD: Here's Why
11:18am, Wednesday, 06'th Sep 2023
Amgen (AMGN) expects strong sales growth of products like Tezspire, Evenity and Repatha to be offset by lower revenues from oncology biosimilars and Enbrel.
3 Growth Stocks to Buy in September
10:56am, Wednesday, 06'th Sep 2023
We're now into September, and that means many investors wonder if the September effect will be in place. This speaks to the historical trend of stocks underperforming in September compared to other mo
The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals
12:56pm, Tuesday, 05'th Sep 2023
Some analysts and M&A experts say the settlement agreement doesn't mean that the FTC will stop baring its teeth at other large buyouts in the industry.
Analysis: FTC settlement could shelter Amgen from US price cuts, taxes
06:05am, Tuesday, 05'th Sep 2023
The U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of Horizon Therapeutics was the latest setback to its stated goal of stricter antitrust enforcement, and instead paved
FTC Allows Amgen (AMGN) to Proceed With $28B Horizon Buyout
01:32pm, Monday, 04'th Sep 2023
Per the settlement terms, Amgen (AMGN) is prohibited from bundling its products with Horizon's Tepezza or Krystexxa. Amgen expects to complete the Horizon acquisition before 2023-end.
Amgen gets green light from FTC for $27.8B Horizon Therapeutics deal
02:11pm, Friday, 01'st Sep 2023
The Federal Trade Commission will allow Amgen to continue a $27.8 billion purchase of Horizon Therapeutics. The companies anticipate closing the deal in the fourth quarter.
Amgen settles with the FTC over $28 billion deal
12:28pm, Friday, 01'st Sep 2023
The Federal Trade Commission will allow pharmaceutical giant Amgen to move ahead with its acquisition of Horizon Therapeutics, averting a trial set for September.
FTC clears Amgen's $28 billion acquisition of Horizon Therapeutics
11:59am, Friday, 01'st Sep 2023
Shares of Horizon Therapeutics PLC (NASDAQ: HZNP) are trading materially up today after the FTC allowed Amgen Inc (NASDAQ: AMGN) to move forward with its $27.8 billion acquisition of the biopharmaceut
As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs
11:30am, Friday, 01'st Sep 2023
As Medicare's years-long drug-price negotiation process is being hotly debated and litigated, some states are plowing ahead with wide-ranging efforts to bring down costs for a potentially much broader
Amgen's $27.8 Billion Purchase Of Horizon Therapeutics On After FTC Settlement
10:53am, Friday, 01'st Sep 2023
The agency previously argued the merger could harm patients who are prescribed Horizon's two fastest-growing drugs.
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
10:32am, Friday, 01'st Sep 2023
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Amgen, Horizon Therapeutics Stocks Rise After FTC Settlement Over $27.8 Billion Merger
10:11am, Friday, 01'st Sep 2023
The Federal Trade Commission makes provision that prohibits “bundling” discounts for some medications.
FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics deal
09:33am, Friday, 01'st Sep 2023
CNBC's Emily Wilkins joins 'Squawk Box' with the latest news.
FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics
09:20am, Friday, 01'st Sep 2023
The Federal Trade Commission reached a deal with Amgen Inc. AMGN, -0.60% to approve its $27.8 billion acquisition of Horizon Therapeutics plc, HZNP, -0.07% the agency announced Friday.
U.S. FTC allows Amgen to move forward with $27.8 bln Horizon deal - CNBC
09:04am, Friday, 01'st Sep 2023
The U.S. Federal Trade Commission has allowed drugmaker Amgen Inc to move ahead with its $27.8 billion deal to buy Horizon Therapeutics , CNBC reported on Friday.
